| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $21.2M | +14.9% |
| SG&A Expense | $10.0M | +1.3% |
| Operating Income | -$31.1M | -10.2% |
| Interest Expense | $604K | -12.2% |
| Pre-tax Income | -$30.0M | -6.1% |
| Income Tax | $1K | +0.0% |
| Net Income | -$30.0M | -6.1% |
| EPS (Basic) | $1.58 | -15.1% |
| EPS (Diluted) | $1.58 | -15.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.8M | -1.9% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $28.2M | -36.1% |
| Total Assets | $30.8M | -34.2% |
| Current Liabilities | $8.5M | -27.0% |
| Total Liabilities | $9.6M | -28.8% |
| Stockholders' Equity | $21.2M | -36.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.8M | -4.9% |
| Capital Expenditures | $613K | +69.8% |
| Investing Cash Flow | $14.5M | +195.8% |
| Financing Cash Flow | $11.8M | +163.1% |
| Free Cash Flow | -$27.4M | -5.8% |